Antiretroviral News and Research

RSS

Alternative anti-HIV strategy generates promising results in a phase I clinical trial

vaccines against the virus, but unfortunately, HIV has numerous defense mechanisms that prevent a person's immune system from mounting an effective response following HIV vaccination.

11 Apr 2022

The effect of unsuppressed HIV on T-cell response to COVID-19

A new study evaluates the impact of HIV infection on SARS-CoV-2 T-cell responses during the first and second waves of COVID-19 in South Africa.

10 Apr 2022

Study investigates the breast milk microbiome in HIV-positive mothers

Infants carry a vast assemblage of bacteria, viruses and fungi in their guts. Combined, these microbes make up a complex ecology known as the gut microbiome, which plays a major role in health and disease throughout life.

6 Apr 2022

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Scientists urge African leaders to demand fair licensing following clinical trials of an HIV vaccine candidate.

30 Mar 2022

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

A preliminary study to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April), suggests that people living with HIV who are on antiretroviral treatment (ART) with protease inhibitors (PI), may have a lower risk of COVID-19 infection.

27 Mar 2022

Study finds high rates of cancer among men living with HIV

Researchers with Case Western Reserve University have found that there are nearly twice as many men with cancer among men living with HIV (MLWH) compared to men who do not have the human immunodeficiency virus.

17 Mar 2022

VOYAGER adjustable tip spacing pipette increases productivity in a real-life situation

INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipettes save time and improve lab productivity, and the company has created a testimonial video showcasing the pipette’s many useful features.

From INTEGRA Biosciences 8 Mar 2022

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Researchers compiled evidence-based recommendations in consultation with European and North American clinicians and pharmacologists for recognizing and managing drug-drug interactions with nirmatrelvir–ritonavir.

3 Mar 2022

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Anthony Cantu, 31, counsels patients at a San Antonio health clinic about a daily pill shown to prevent HIV infection.

3 Mar 2022

HIV patient treated with blood stem cell transplant for leukemia achieves long-term remission

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine physician-scientists who performed the transplant and managed her care

21 Feb 2022

Emergence of new HIV variant underscores importance of monitoring virus mutations

A new study published in the journal Science reported the presence of a subtype-B variant of HIV-1 with remarkably high virulence, circulating in the Netherlands during the past two decades.

20 Feb 2022

Early antiretroviral therapy is crucial to fight against HIV and latent tuberculosis

Two weeks makes a big difference in treating the animal version of HIV and latent tuberculosis, researchers from Texas Biomedical Research Institute, Southwest National Primate Research Center and colleagues report this month in the Journal of Clinical Investigation.

18 Feb 2022

A third known case of HIV remission involving stem cell transplant documented

A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation at today's Conference on Retroviruses and Opportunistic Infections (CROI).

15 Feb 2022

Antiretroviral News and Research

Alternative anti-HIV strategy generates promising results in a phase I clinical trial

The effect of unsuppressed HIV on T-cell response to COVID-19

Study investigates the breast milk microbiome in HIV-positive mothers

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

Study finds high rates of cancer among men living with HIV

VOYAGER adjustable tip spacing pipette increases productivity in a real-life situation

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

HIV patient treated with blood stem cell transplant for leukemia achieves long-term remission

Emergence of new HIV variant underscores importance of monitoring virus mutations

Early antiretroviral therapy is crucial to fight against HIV and latent tuberculosis

A third known case of HIV remission involving stem cell transplant documented

Novel fast-spreading HIV-1 variant found circulating in the Netherlands

Study underscores the urgent need to accelerate testing to identify undiagnosed children with HIV

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows

Novel SARS-CoV-2 mutations reported in chronic HIV patients

FAU receives $1.3 million NIH grant for automated HIV self-testing assay

UCLA-led researchers improve method that was designed to kill HIV-infected cells

Study finds rise in marijuana use among pregnant and postpartum people living with HIV

Snapping at new biotech breakthroughs with Gator Pro

Realizing the Importance of Medical Electronic Devices

Everything about SpatialOMx

Latest News

Lab Diagnostics and Automation eBook